Skip to main content
SpringerLink
Log in

US FDA reviewing safety of botulinum toxin type A and B

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. US Food & Drug Administration.Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin Type A) and Myobloc (botulinum toxin Type B). Internet Document: [3 pages], No. 26, 8 Feb 2008. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

US FDA reviewing safety of botulinum toxin type A and B. React. Wkly. 1189, 2 (2008). https://doi.org/10.2165/00128415-200811890-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811890-00002

Keywords

Search

Navigation